Jon Sakoda - Net Worth and Insider Trading
Jon Sakoda Net Worth
The estimated net worth of Jon Sakoda is at least $73 Million dollars as of 2024-05-05. Jon Sakoda is the 10% Owner of Ardelyx Inc and owns about 5,331,039 shares of Ardelyx Inc (ARDX) stock worth over $46 Million. Jon Sakoda is the 10% Owner of AVEO Pharmaceuticals Inc and owns about 1,778,372 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $27 Million. Jon Sakoda is also the 10% Owner of Achaogen Inc and owns about 5,215,128 shares of Achaogen Inc (AKAOQ) stock worth over $130,378. Besides these, Jon Sakoda also holds ARCA biopharma Inc (ABIO) . Details can be seen in Jon Sakoda's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jon Sakoda has not made any transactions after 2018-06-28 and currently still holds the listed stock(s).
Transaction Summary of Jon Sakoda
Jon Sakoda Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jon Sakoda owns 10 companies in total, including AVEO Pharmaceuticals Inc (AVEO) , Ardelyx Inc (ARDX) , and Cascadian Therapeutics Inc (CASC) among others .
Click here to see the complete history of Jon Sakoda’s form 4 insider trades.
Insider Ownership Summary of Jon Sakoda
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVEO | AVEO Pharmaceuticals Inc | 2018-06-28 | 10 percent owner |
| ARDX | Ardelyx Inc | 2016-07-18 | 10 percent owner |
| CASC | Cascadian Therapeutics Inc | 2018-03-09 | 10 percent owner |
 | | 2018-02-26 | 10 percent owner |
| | 2018-01-19 | 10 percent owner |
| | 2017-11-20 | 10 percent owner |
| | 2017-07-24 | 10 percent owner |
| | 2016-12-19 | 10 percent owner |
| | 2015-05-27 | director |
| | 2018-01-19 | 10 percent owner |
Jon Sakoda Latest Holdings Summary
Jon Sakoda currently owns a total of 4 stocks. Among these stocks, Jon Sakoda owns 5,331,039 shares of Ardelyx Inc (ARDX) as of July 18, 2016, with a value of $46 Million and a weighting of 63.43%. Jon Sakoda owns 1,778,372 shares of AVEO Pharmaceuticals Inc (AVEO) as of June 28, 2018, with a value of $27 Million and a weighting of 36.4%. Jon Sakoda also owns 5,215,128 shares of Achaogen Inc (AKAOQ) as of December 19, 2016, with a value of $130,378 and a weighting of 0.18%. The other 1 stocks ARCA biopharma Inc (ABIO) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Jon Sakoda
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARDX | Ardelyx Inc | 2016-07-18 | 5,331,039 | 8.72 | 46,486,660 |
| AVEO | AVEO Pharmaceuticals Inc | 2018-06-28 | 1,778,372 | 15.00 | 26,675,580 |
| AKAOQ | Achaogen Inc | 2016-12-19 | 5,215,128 | 0.03 | 130,378 |
| ABIO | ARCA biopharma Inc | 2018-02-26 | 0 | 3.26 | 0 |
Holding Weightings of Jon Sakoda
Jon Sakoda Form 4 Trading Tracker
According to the SEC Form 4 filings, Jon Sakoda has made a total of 0 transactions in Ardelyx Inc (ARDX) over the past 5 years. The most-recent trade in Ardelyx Inc is the acquisition of 1,527,301 shares on July 18, 2016, which cost Jon Sakoda around $13 Million.
According to the SEC Form 4 filings, Jon Sakoda has made a total of 0 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years. The most-recent trade in AVEO Pharmaceuticals Inc is the acquisition of 19,243 shares on June 28, 2018, which cost Jon Sakoda around $404,092.
According to the SEC Form 4 filings, Jon Sakoda has made a total of 0 transactions in Achaogen Inc (AKAOQ) over the past 5 years. The most-recent trade in Achaogen Inc is the acquisition of 500,000 shares on December 19, 2016, which cost Jon Sakoda around $7 Million.
More details on Jon Sakoda's insider transactions can be found in the Insider Trading History of Jon Sakoda table.Insider Trading History of Jon Sakoda
- 1
Jon Sakoda Trading Performance
GuruFocus tracks the stock performance after each of Jon Sakoda's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jon Sakoda is 55.22%. GuruFocus also compares Jon Sakoda's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jon Sakoda within 3 months outperforms 7 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jon Sakoda's insider trading performs compared to the benchmark.
Performance of Jon Sakoda
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.53 | | | | | |
| Relative Return to S&P 500(%) | 6.08 | | | | | |
Jon Sakoda Ownership Network
Jon Sakoda Owned Company Details
What does AVEO Pharmaceuticals Inc do?
Who are the key executives at AVEO Pharmaceuticals Inc?
Jon Sakoda is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .
AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AVEO Pharmaceuticals Inc Insider Transactions
Jon Sakoda Mailing Address
Above is the net worth, insider trading, and ownership report for Jon Sakoda. You might contact Jon Sakoda via mailing address: 2855 Sand Hill Road, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
